Mgc Pharmaceuticals
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 2 Apr 2024
- Reported shorts
- 218
- Shares on issue
- 43.852M
Mgc Pharmaceuticals (MXC) Short Interest
Mgc Pharmaceuticals (ASX:MXC) had 0.00% of shares reported as short positions as of 2 Apr 2024, representing 218 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Mgc Pharmaceuticals
MGC Pharmaceuticals is a biopharmaceutical company specializing in the production and development of phytocannabinoid-derived medicines. The company is positioned in the healthcare industry, focusing on innovative treatments for various medical conditions. MGC leverages its expertise in cannabis-based products to offer unique therapeutic solutions.
Company profile →Mgc Pharmaceuticals (ASX:MXC) has 0.00% of its shares on issue reported as short positions as of 2 Apr 2024, or about 218 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.76% in March 2017. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Latest MXC news
All news- MGC Pharmaceuticals (ASX:MXC): Is Funding Risk the Key Signal?
kalkine · 4 Aug 2026
- Why Is MXC Testing Australia’s Cannabis Market Reset?
kalkine · 10 July 2026
Be the first to discuss MXC
Start a research thread or post the first pulse update